These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30108006)

  • 41. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.
    Munawar I; Yaremko BP; Craig J; Oliver M; Gaede S; Rodrigues G; Yu E; Reid RH; Leung E; Urbain JL; Chen J; Wong E
    Med Phys; 2010 Apr; 37(4):1863-72. PubMed ID: 20443508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiation-induced Hounsfield unit change correlates with dynamic CT perfusion better than 4DCT-based ventilation measures in a novel-swine model.
    Wuschner AE; Wallat EM; Flakus MJ; Shanmuganayagam D; Meudt J; Christensen GE; Reinhardt JM; Miller JR; Lawless MJ; Baschnagel AM; Bayouth JE
    Sci Rep; 2021 Jun; 11(1):13156. PubMed ID: 34162987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Integration of computerized tomography imaging with single photon emission in a commercial system for developing radiotherapy fields: application to conformational irradiation for lung carcinoma].
    Cattaneo GM; Rizzo G; Lombardi P; Ceresoli G; Savi A; Gilardi MC; Villa E; Calandrino R
    Radiol Med; 1999 Apr; 97(4):272-8. PubMed ID: 10414261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantification of CT-assessed radiation-induced lung damage in lung cancer patients treated with or without chemotherapy and cetuximab.
    Sharifi H; van Elmpt W; Oberije C; Nalbantov G; Das M; Öllers M; Lambin P; Dingmans AM; De Ruysscher D
    Acta Oncol; 2016; 55(2):156-62. PubMed ID: 26399389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.
    Liu C; Schild SE; Chang JY; Liao Z; Korte S; Shen J; Ding X; Hu Y; Kang Y; Keole SR; Sio TT; Wong WW; Sahoo N; Bues M; Liu W
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):479-489. PubMed ID: 29550033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of predictive powers of functional and anatomic dosimetric parameters for radiation-induced lung toxicity in locally advanced non-small cell lung cancer.
    Xiao L; Yang G; Chen J; Yang Y; Meng X; Wang X; Wu Q; Huo Z; Yu Q; Yu J; Kong FS; Yuan S
    Radiother Oncol; 2018 Nov; 129(2):242-248. PubMed ID: 30471708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha/beta ratio for normal lung tissue as estimated from lung cancer patients treated with stereotactic body and conventionally fractionated radiation therapy.
    Scheenstra AE; Rossi MM; Belderbos JS; Damen EM; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):224-8. PubMed ID: 24331668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose escalation of radical radiation therapy in non-small-cell lung cancer using positron emission tomography/computed tomography-defined target volumes: are class solutions obsolete?
    Everitt S; Schneider-Kolsky M; Yuen K; Budd R; Mac Manus M
    J Med Imaging Radiat Oncol; 2008 Apr; 52(2):168-77. PubMed ID: 18373810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Utility of SPECT lung perfusion scans in assessing early changes in pulmonary function of patients with lung cancer after radiotherapy].
    Zhang WJ; Zheng R; Zhao LJ; Wang LH; Chen SZ
    Ai Zheng; 2004 Oct; 23(10):1180-4. PubMed ID: 15473931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional dose response to pulmonary irradiation using a manual method.
    Levinson B; Marks LB; Munley MT; Poulson J; Hollis D; Jaszczak R; Coleman RE
    Radiother Oncol; 1998 Jul; 48(1):53-60. PubMed ID: 9756172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.
    Britton KR; Starkschall G; Liu H; Chang JY; Bilton S; Ezhil M; John-Baptiste S; Kantor M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):94-102. PubMed ID: 18929448
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of atelectasis changes on tissue mass and dose during lung radiotherapy.
    Guy CL; Weiss E; Jan N; Reshko LB; Christensen GE; Hugo GD
    Med Phys; 2016 Nov; 43(11):6109. PubMed ID: 27806593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer.
    Christian JA; Partridge M; Nioutsikou E; Cook G; McNair HA; Cronin B; Courbon F; Bedford JL; Brada M
    Radiother Oncol; 2005 Dec; 77(3):271-7. PubMed ID: 16274762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.
    Willner J; Baier K; Caragiani E; Tschammler A; Flentje M
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):382-9. PubMed ID: 11872283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
    Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
    Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer.
    Jan N; Guy C; Reshko LB; Hugo GD; Weiss E
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):683-690. PubMed ID: 28581410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning.
    Xiao J; Zhang H; Gong Y; Fu Y; Tang B; Wang S; Jiang Q; Li P
    Radiother Oncol; 2010 Jul; 96(1):73-7. PubMed ID: 20347496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
    Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):56-61. PubMed ID: 11516851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.